Skip to search formSkip to main contentSkip to account menu

huN901-DM1

National Institutes of Health

Related topics

Related topics

3 relations
BB-10901

Broader (2)

ado-trastuzumab emtansinelorvotuzumab mertansine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Efficacy of IMGN901 (huN901-DM1) in combination with bortezomib and lenalidomide against multiple myeloma cells in preclinical studies
2146 IMGN901 (huN901-DM1) is an antibody-maytansinoid conjugate which targets CD56 and is being evaluated as a single agent in… 
2008
2008
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901‐DM1): a potential therapeutic modality implication against natural killer/T cell malignancy
patient. The gaps in therapy for Patient 3 were produced by attempts to discontinue decitabine then darbopoietin when haemoglobin… 
2007
2007
Phase I Study of huN901-DM1 (BB-10901) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.
Background: huN901-DM1 (BB-10901) is a humanized monoclonal antibody that binds with high affinity to CD56 and is covalently… 
2006
2006
649 POSTER Phase I trial of BB-10901 (huN901-DM1) given daily by IV infusion for three consecutive days every three weeks in patients with SCLC and other CD56-positive solid tumors
2006
2006
Phase I Study of BB-10901 (huN901-DM1) in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma.
Background: BB-10901 is a humanized monoclonal antibody that binds with high affinity to CD56 and is covalently linked to a novel… 
2005
2005
Technology evaluation: huN901-DM1, ImmunoGen.
  • Suzanne V. Smith
  • Current opinion in molecular therapeutics (Print)
  • 2005
  • Corpus ID: 7706870
ImmunoGen is developing huN901-DMI, a compound comprised of a CD56-targeted humanized N901 antibody conjugated to the company's… 
Highly Cited
2004
Highly Cited
2004
In Vitro and in Vivo Activity of the Maytansinoid Immunoconjugate huN901-N2′-Deacetyl-N2′-(3-Mercapto-1-Oxopropyl)-Maytansine against CD56+ Multiple Myeloma Cells
HuN901 is a humanized monoclonal antibody that binds with high affinity to CD56, the neuronal cell adhesion molecule. HuN901… 
2003
2003
In vitro and in vivo antitumor activity of the maytansinoid immunoconjugate BB-10901 (huN901-DM1) on CD56+multiple myeloma cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)